![]() |
市場調查報告書
商品編碼
1663308
磁振造影設備 (MRI) 設備:市場洞察·競爭情形·市場預測 (~2032年)Magnetic Resonance Imaging (MRI) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 |
磁振造影 (MRI) 設備市場規模預計將從 2024 年的 82.0706 億美元成長到 2032 年的 135.5333 億美元,預測期內的複合年增長率為 6.54%。
心血管疾病、癌症和神經系統疾病等各種慢性疾病的發生率不斷上升,刺激了對 MRI 等精密診斷工具的需求,這些工具具有對軟組織和器官的卓越成像能力。此外,人們對慢性病早期診斷的認識不斷提高和關注度不斷擴大,正在鼓勵患者和醫療保健提供者採用 MRI 進行及時幹預。此外,更高場域、開放式 MRI 系統和更快的功能性 MRI (fMRI) 掃描時間等技術創新正在提高成像過程的準確性、舒適度和效率。由於這些因素,預計預測期內全球對該設備的需求將會成長。
市場動態:
根據GLOBOCAN(2024)的最新數據,2022年全球預計將有2000萬例新發癌症病例,預計到2045年將增加到3260萬例。 MRI 在腫瘤學領域發揮著至關重要的作用,它提供高度詳細的軟組織影像,這對於檢測大腦、乳房、肝臟、前列腺和胰臟等器官的腫瘤至關重要。隨著全球癌症負擔的不斷加重,對無需讓患者暴露於電離輻射即可準確識別位置、評估大小和確定腫瘤分期的先進成像技術的需求激增,這推動了全球市場的成長。
聚焦在神經系統癌症,GLOBOCAN (2022) 的數據顯示,全球腦和中樞神經系統 (CNS) 癌症發生率約為 322,000 例,預計到 2045 年將增加到 474,000 例。同時,英國心臟基金會(2024年)估計,全球約有1億中風倖存者,其中5,600萬人為女性,4,500萬人為男性。 MRI 是一種非侵入性檢查,可以識別正常和異常的腦組織,是診斷腦腫瘤、中樞神經系統癌症和其他神經系統疾病的重要工具。在卒中診斷中,作為一種專門的MRI技術,擴散加權成像(DWI)對於早期發現缺血性中風、評估腦組織損傷和指導及時幹預至關重要。透過 MRI 進行早期檢測不僅有助於快速做出治療決定,而且還能最大限度地減少長期併發症,從而進一步推動對這些機器的需求。
技術進步和新產品的推出也持續推動 MRI 市場的發展。例如,日立醫療系統於2021年3月的歐洲放射學大會上推出了兩台永久安裝的開放式MRI系統。這兩種系統都與 SynergyDrive 工作流程解決方案集成,以提高成像速度、效率和患者舒適度。這些創新滿足了關鍵的臨床需求,同時改善了醫療機構的營運工作流程。
儘管取得了這些進步,但仍存在一些課題可能會阻礙市場成長。由於安全問題或技術故障而導致的產品召回增加可能會削弱用戶信心並減緩設備的採用。此外,雖然對於確保病患安全至關重要,但嚴格的設備審批監管要求可能會延遲創新產品的市場推出。
本報告提供全球磁振造影設備 (MRI) 設備的市場調查,彙整市場概要,市場影響因素及市場機會分析,法律制度,市場規模的轉變·預測,各種區分·地區/各主要國家的詳細分析,競爭情形,主要企業簡介等資訊。
Magnetic Resonance Imaging (MRI) Devices Market by Field Strength (High-Field MRI Systems (1.5t to 3t), Low-to-Mid-Field MRI Systems (<1.5t), and Very-High-Field MRI Systems (4t And Above), Architecture (Closed MRI Systems, Wide-Bore MRI, and Open MRI Systems), Application (Musculoskeletal, Gastroenterology, Neurology, Oncology, and Others), End-User (Hospitals, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising prevalence of various chronic disorders, increasing awareness and early diagnosis, growing technological advancements, and increase in product development activities by key market players across the globe.
The magnetic resonance imaging devices market was valued at USD 8,207.06 million in 2024, growing at a CAGR of 6.54% during the forecast period from 2025 to 2032 to reach USD 13,553.33 million by 2032. The rising prevalence of various chronic disorders, such as cardiovascular diseases, cancer, and neurological conditions, is fueling the demand for precise diagnostic tools like MRI, which offers superior imaging capabilities for soft tissues and organs. Additionally, the increasing awareness and the emphasis on early diagnosis of chronic disease are encouraging patients and healthcare providers to adopt MRI for timely intervention. Furthermore, technological advancements play a crucial role in boosting the MRI market, with innovations such as high-field and open MRI systems, functional MRI (fMRI), and faster scan times improving the accuracy, comfort, and efficiency of the imaging process. Collectively, these factors are expected to expand the demand for magnetic resonance imaging devices globally during the forecast period from 2025 to 2032.
Magnetic Resonance Imaging Devices Market Dynamics:
According to recent data from GLOBOCAN (2024), there were an estimated 20 million new cancer cases worldwide in 2022, with projections indicating a rise to 32.6 million by 2045. Magnetic resonance imaging (MRI) devices play a pivotal role in oncology, offering highly detailed soft tissue images that are crucial for detecting tumors in organs such as the brain, breast, liver, prostate, and pancreas. As the global cancer burden intensifies, there is a surging demand for advanced imaging technologies capable of precisely locating tumors, evaluating their size, and determining disease stage all without exposing patients to ionizing radiation thereby driving the global market growth.
Focusing on neurological cancers, GLOBOCAN (2022) data reveals that the global incidence of brain and central nervous system (CNS) cancers was approximately 322,000 cases, with projections set to increase to 474,000 by 2045. Concurrently, the British Heart Foundation (2024) estimates that there are about 100 million stroke survivors worldwide, including 56 million women and 45 million men. MRI's non-invasive nature and ability to distinguish between normal and abnormal brain tissues make it an essential tool for diagnosing brain tumors, CNS cancers, and other neurological conditions. In stroke diagnosis, diffusion-weighted imaging (DWI) a specialized MRI technique is vital for early identification of ischemic strokes, assessing brain tissue damage, and guiding timely interventions. Early detection through MRI not only facilitates rapid treatment decisions but also minimizes long-term complications, further propelling demand for these devices.
Technological advancements and new product launches continue to strengthen the MRI market. For instance, in March 2021, Hitachi Medical Systems launched two permanent open MRI systems at the European Congress of Radiology, both integrated with the SynergyDrive workflow solution to enhance imaging speed, efficiency, and patient comfort. Such innovations address key clinical needs while improving operational workflows in healthcare facilities.
Despite these advancements, certain challenges could impede market growth. A rising number of product recalls often due to safety concerns or technical malfunctions can undermine user confidence and delay device adoption. Additionally, stringent regulatory requirements for device approval, though essential for patient safety, may slow down the introduction of innovative products to the market.
In conclusion, while increasing cancer incidence, technological innovations, and rising neurological and cardiovascular disease prevalence continue to drive the global MRI devices market, overcoming regulatory hurdles and addressing product reliability issues will be crucial to sustaining long-term growth.
Magnetic Resonance Imaging Devices Market Segment Analysis:
Magnetic Resonance Imaging (MRI) Devices Market by Field Strength (High-Field MRI Systems (1.5t to 3t), Low-to-Mid-Field MRI Systems (<1.5t), and Very-High-Field MRI Systems (4t And Above), Architecture (Closed MRI Systems, Wide-Bore MRI, and Open MRI Systems), Application (Musculoskeletal, Gastroenterology, Neurology, Oncology, and Others), End-User (Hospitals, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the field strength segment of the global magnetic resonance imaging (MRI) devices market, high-field MRI systems (1.5T to 3T) are projected to hold the largest market share in 2024. These systems are driving overall market growth due to their superior imaging capabilities, making them the preferred choice for a wide range of clinical applications. High-field MRIs offer higher spatial resolution, faster scan times, and enhanced diagnostic accuracy compared to lower-field MRI machines, enabling detailed visualization of fine anatomical structures. This makes them particularly valuable for brain, spine, and cardiovascular imaging, where precise anatomical details are crucial for accurate diagnosis and treatment planning.
One of the significant advantages of high-field MRI systems is their ability to support advanced functional imaging techniques such as functional MRI (fMRI) and diffusion tensor imaging (DTI), both essential for neurological assessments and pre-surgical planning. In oncology, high-field MRIs play a vital role in detecting and monitoring tumors, especially in anatomically challenging areas like the prostate, liver, and pancreas, where early detection significantly impacts patient outcomes. Moreover, the rising prevalence of chronic diseases, increasing demand for early diagnosis, and the growing number of MRI installations in hospitals, diagnostic centers, and research institutions are further fueling the adoption of these systems.
Technological advancements have also contributed to the market expansion of high-field MRI systems. Innovations such as faster acquisition sequences, motion correction technologies, and AI-powered image reconstruction are improving image quality while reducing scan times and patient discomfort. Additionally, the development of open high-field MRI systems addresses the common issue of patient claustrophobia and expands the usability of MRI for pediatric, elderly, and bariatric patients.
For instance, on November 29, 2021, FUJIFILM Healthcare Americas Corporation launched its advanced high-field open MRI system the Velocity MRI System during the 2021 Radiological Society of North America (RSNA) conference. This system is designed to streamline workflow and enhance patient comfort with its unique open gantry, integrated radiofrequency (RF) coils, and advanced reconstruction technologies. Notably, the Synergy Flex coil, the first of its kind in an open, vertical-field MRI scanner, promotes fast and efficient abdominal and orthopedic imaging. Such innovations are pivotal in expanding MRI accessibility while maintaining high diagnostic performance.
Despite these advancements, challenges such as high equipment costs, installation complexities, and strict regulatory requirements for product approvals may pose hurdles to market growth. However, the increasing demand for non-invasive diagnostic imaging, coupled with technological innovations aimed at improving patient comfort and operational efficiency, is expected to generate substantial revenue and propel the growth of the global high-field MRI devices segment throughout the forecast period.
North America is expected to dominate the overall magnetic resonance imaging devices market:
Among all regions, North America is projected to hold the largest share in the global magnetic resonance imaging (MRI) devices market in 2024. This dominance can be attributed to several factors, including the rising prevalence of neurological disorders, cardiovascular diseases, and cancer, coupled with technological advancements, favorable government initiatives, and the strong presence of key market players engaged in strategic activities across the region.
The growing burden of neurological disorders is a significant driver. According to the Alzheimer's Association (2024), approximately 6.9 million Americans aged 65 and older are living with Alzheimer's disease. Similarly, data from the Parkinson's Foundation (2022) indicates that nearly 90,000 people are diagnosed with Parkinson's disease annually in the U.S., with approximately one million Americans living with the condition a figure expected to rise to 1.2 million by 2030. MRI's capability to deliver high-resolution images and advanced functional imaging techniques, such as functional MRI (fMRI) and magnetic resonance spectroscopy (MRS), plays a crucial role in detecting early structural and functional brain changes, thereby aiding in the diagnosis and management of these neurodegenerative diseases.
Cancer prevalence further accelerates the demand for MRI systems in North America. As per GLOBOCAN (2024), the region reported an estimated 2.67 million new cancer cases in 2022, with projections reaching 3.83 million by 2045. For cancers located in complex anatomical areas such as the brain, spinal cord, and pelvis MRI offers superior imaging compared to other modalities, enhancing tumor detection, treatment planning, and monitoring. This increased demand for precise, non-invasive imaging solutions is a key factor propelling the market.
Technological innovation and regulatory approvals also play a pivotal role in market expansion. In January 2024, Siemens Healthineers received FDA clearance for its MAGNETOM Cima.X 3 Tesla (3T) whole-body MRI scanner. This next-generation system features the strongest gradient system ever released for clinical use in whole-body imaging, allowing for faster scan times and enhanced visualization of small anatomical structures. The MAGNETOM Cima.X is designed to address critical imaging challenges, especially in cancer diagnostics, and supports advanced research with features tailored for complex imaging requirements.
Furthermore, the active involvement of key market players in launching new products, forming strategic partnerships, and expanding their regional presence continues to bolster market growth. Government initiatives aimed at improving diagnostic infrastructure and enhancing access to advanced medical technologies further strengthen the region's market position.
In conclusion, the interplay of rising disease prevalence, technological advancements, regulatory support, and strategic industry initiatives is expected to significantly boost the adoption of MRI devices in North America, driving substantial market growth throughout the forecast period.
Magnetic Resonance Imaging Devices Market Key Players:
Some of the key market players operating in the magnetic resonance Imaging devices market include General Electric Company, FUJIFILM Holdings Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, ESAOTE SPA, Aspect Imaging Ltd., Bruker Corporation, Aurora Healthcare US Corp., FONAR Corp., Neusoft Medical Systems Co., Ltd., Shenzhen Anke High-Tech Co. Ltd., Shenzhen Basda Medical Apparatus Co. Ltd., Time Medical Holding, Hyperfine, Alltech Medical Systems, InnerVision MRI Ltd., Magnetica Limited, IMRIS, Deerfield Imaging, Inc., and others.
Recent Developmental Activities in the Magnetic Resonance Imaging Devices Market:
Key Takeaways from the Magnetic Resonance Imaging Devices Market Report Study:
Target Audience Who Can be Benefited from this Magnetic Resonance Imaging Devices Market Report Study:
Frequently Asked Questions for the Magnetic Resonance Imaging Devices Market: